Abstract
Parathyroid hormone analogue PTH(1–34), used clinically to treat osteoporosis, forms a stable complex with its receptor and prolongs cAMP production even after internalization and recruitment to endosomes. New data suggests this signaling cascade is stimulated by β-arrestins and terminated by retromer.